T. Rowe Price Associates’s SELLAS Life Sciences SLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $78K | Hold |
|
|||||
|
2025
Q2 | $106K | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $25K | Hold |
|
|||||
|
2022
Q4 | $40K | Hold |
|
|||||
|
2022
Q3 | $35K | Hold |
|
|||||
|
2022
Q2 | $38K | Hold |
|
|||||
|
2022
Q1 | $114K | Hold |
|
|||||
|
2021
Q4 | $95K | Buy |
|
|||||
|
2021
Q3 | $98K | Sell |
|
|||||
|
2021
Q2 | $172K | Sell |
|
|||||
|
2021
Q1 | $231K | Buy |
|